- $276.84m
- $280.27m
Annual income statement for USBC, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | C2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.122 | 0 | 4.36 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.052 | 0 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.66 | 10.4 | 16.9 | 14.3 | 15.2 |
| Operating Profit | -7.53 | -10.4 | -12.6 | -14.3 | -15.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.6 | -25.4 | -20.1 | -15.3 | -16.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.6 | -25.4 | -20.1 | -15.3 | -16.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.6 | -25.4 | -20.1 | -15.3 | -16.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.6 | -25.4 | -20.1 | -20.4 | -16.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -23.6 | -34.5 | -19.9 | -16.3 | -7.85 |